MDL 72832

Known as: 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)amino)butyl)-, (+-)-, MDL-72832 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We wanted to determine which alpha-adrenoceptor subtypes mediate phenylephrine (PE) contraction of dog mesenteric artery in vitro… (More)
Is this relevant?
Review
1999
Review
1999
We wanted to determine which a-adrenoceptor subtypes mediate phenylephrine (PE) contraction of dog mesenteric artery in vitro. We… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
1998
1998
In this study, the effects of nine alpha-1 adrenoceptor antagonists [prazosin, WB 4101 (WB), chloroethylclonidine (CEC), 5… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 4
Is this relevant?
1997
1997
In this study we examined the effects of 5-HT1A ligands in rats trained to discriminate 0.16 mg/kg i.p. 8-hydroxy-2-(di-n… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1992
1992
The effects of four 5-HT1-like receptor agonists (8-OH-DPAT, RU 24969, BEA 1654 and 5-carboxamidotryptamine) and some putative 5… (More)
Is this relevant?
1989
1989
In a previous study it was found that the anxiolytic drug buspirone and the related compounds gepirone and ipsapirone disrupted… (More)
Is this relevant?